Vol. 8, Issue 7 (2019)
HIV-TB co-infection among ICTC attendees in a tertiary care teaching hospital Hyderabad
Ranganath Reddy Rachamallu, T Suvarna, Soumendra Nath Maity, Sai Sailesh Kumar Goothy, V Ramakrishna and Ratnagiri Polavarapu
The emergence of Human immunodeficiency virus (HIV) and Tuberculosis (TB) co-infection created a serious threat worldwide. In recent scenario multidrug resistant TB have become more prevalent. Therefore HIV and TB co-infection is major health problem globally, mostly in developing countries like India. Materials and Methods: This cross-sectional study was conducted in ICTC centre of Malla Reddy Hospital, Hyderabad. A total of 2,500 individuals attended ICTC were included in this study. HIV status was confirmed as per NACO guidelines and TB diagnosis as per RNTCP guidelines.
Results: Over all TB was reported 45% of HIV infected patients as compared to 33% in seronegative patients, which was statistically significant. The prevalence rate of pulmonary TB was higher in HIV reactive individuals. Conclusion- An optimum strategy be devised to monitor and act on the issue of HIV-TB co-infection so as to facilitate early diagnosis, treatment and prevention of this co-infection. Such a strategy will not only allow for a reduction of the total tuberculosis load in the community, but will also positively impact the lives of PLHA (People Living with HIV/AIDS) both qualitatively and quantitatively.
How to cite this article:
Ranganath Reddy Rachamallu, T Suvarna, Soumendra Nath Maity, Sai Sailesh Kumar Goothy, V Ramakrishna and Ratnagiri Polavarapu. . The Pharma Innovation Journal. 2019; 8(7): 18-22.